{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:53:42Z","timestamp":1785556422982,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015345","name":"ZOLL Medical Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cct.2025.107918","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:17:42Z","timestamp":1744733862000},"page":"107918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Using Bayesian pre-trial simulations to optimize the design of adaptive clinical trials in childhood nephrotic syndrome"],"prefix":"10.1016","volume":"153","author":[{"given":"Cal H.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2025.107918_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2025.107918_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/archdischild-2019-318676","article-title":"Challenges in clinical trials for children and young people","volume":"106","author":"Lagler","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cct.2025.107918_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s43586-022-00100-2","article-title":"Designing clinical trials for rare diseases: unique challenges and opportunities","volume":"2","author":"Pizzamiglio","year":"2022","journal-title":"Nat. Rev. Methods Primer"},{"key":"10.1016\/j.cct.2025.107918_bb0020","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00467-023-05877-2","article-title":"The urgent need for conducting clinical trials in pediatric nephrology globally","volume":"38","author":"Wightman","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cct.2025.107918_bb0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/children7120293","article-title":"Publication trends of pediatric and adult randomized controlled trials in general medical journals, 2005\u20132018: a citation analysis","volume":"7","author":"Groff","year":"2020","journal-title":"Children"},{"key":"10.1016\/j.cct.2025.107918_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jclinepi.2006.03.015","article-title":"An absence of pediatric randomized controlled trials in general medical journals, 1985\u20132004","volume":"60","author":"Cohen","year":"2007","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.cct.2025.107918_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5829","article-title":"Evaluation of publication of pediatric drug trials","volume":"4","author":"Srivastava","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cct.2025.107918_bb0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jama.2022.24025","article-title":"Dissemination of the results of pediatric clinical trials funded by the US National Institutes of Health","volume":"329","author":"Rees","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2025.107918_bb0045","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0223","article-title":"Discontinuation and nonpublication of randomized clinical trials conducted in children","volume":"138","author":"Pica","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.cct.2025.107918_bb0050","series-title":"Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry","article-title":"Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)","author":"U.S. Department of Health and Human Services","year":"2019"},{"key":"10.1016\/j.cct.2025.107918_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.cct.2025.107918_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/CLEP.S156708","article-title":"Critical concepts in adaptive clinical trials","volume":"10","author":"Park","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.cct.2025.107918_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials","volume":"5","author":"Berry","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cct.2025.107918_bb0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/resp.14337","article-title":"Bayesian adaptive clinical trial designs for respiratory medicine","volume":"27","author":"Ryan","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.cct.2025.107918_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJMra1510061","article-title":"Adaptive designs for clinical trials","volume":"375","author":"Bhatt","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2025.107918_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12874-022-01603-y","article-title":"Improving clinical trials using Bayesian adaptive designs: a breast cancer example","volume":"22","author":"Hong","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.cct.2025.107918_bb0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4155\/cli.15.14","article-title":"Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials","volume":"5","author":"Hummel","year":"2015","journal-title":"Clin. Investig."},{"key":"10.1016\/j.cct.2025.107918_bb0090","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/sim.8086","article-title":"Using simulation studies to evaluate statistical methods","volume":"38","author":"Morris","year":"2019","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2025.107918_bb0095","article-title":"Abstracts \u2013 IPNA 2025 congress","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cct.2025.107918_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00431-019-03506-5","article-title":"Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study","volume":"179","author":"Borovitz","year":"2020","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cct.2025.107918_bb0105","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s00467-021-05048-1","article-title":"Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial","volume":"36","author":"Sheikh","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cct.2025.107918_bb0110","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.21105\/joss.04284","article-title":"Adaptr: an R package for simulating and comparingadaptive clinical trials","volume":"7","author":"Granholm","year":"2022","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.cct.2025.107918_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/adc.64.4.610","article-title":"Low dose prednisolone in nephrotic syndrome","volume":"64","author":"Choonara","year":"1989","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cct.2025.107918_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00467-016-3458-6","article-title":"Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children","volume":"32","author":"Raja","year":"2017","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cct.2025.107918_bb0125","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00467-018-4064-6","article-title":"Initial prednisolone dosing for the first relapse of steroid-sensitive nephrotic syndrome in Japanese children","volume":"33","author":"Fujinaga","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cct.2025.107918_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.1053","article-title":"Innovative study designs optimizing clinical pharmacology research in infants and children","volume":"58","author":"Balevic","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2025.107918_bb0135","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/pr.2017.163","article-title":"Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics","volume":"82","author":"Huff","year":"2017","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cct.2025.107918_bb0140","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/sim.5404","article-title":"Bayesian clinical trials in action","volume":"31","author":"Lee","year":"2012","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2025.107918_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2024.107560","article-title":"Designing a Bayesian adaptive clinical trial to evaluate novel mechanical ventilation strategies in acute respiratory failure using integrated nested Laplace approximations","author":"Hosseini","year":"2024","journal-title":"Contemp. Clin. Trials"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:21:34Z","timestamp":1778224894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714425001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"alternative-id":["S1551714425001120"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2025.107918","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Bayesian pre-trial simulations to optimize the design of adaptive clinical trials in childhood nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2025.107918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107918"}}